Table 2.
Associated treatment | n | % |
---|---|---|
Cetuximab + Cisplatin | 34 | 14.2 |
Cetuximab + Carboplatin | 17 | 7.1 |
Cisplatin | 106 | 44.2 |
Cisplatin + Taxol | 50 | 20.8 |
Carboplatin | 26 | 10.8 |
Other regimen (Gemcitabine, Dacarbazine, Cetuximab, Cisplatin, Carboplatin) | 6 | 2.5 |
Not reported | 1 | 0.4 |